Section 2 Fetal Malformation

### **Chapter 6**

## Prenatal Diagnosis of Diaphragmatic Hernia

*Marina Sica, Carlotta Plessi and Francesco Molinaro*

### **Abstract**

Congenital diaphragmatic hernia (CDH) is a condition characterized by a defect in the diaphragm leading to protrusion of abdominal contents into the thoracic cavity interfering with normal development of the lungs. The pathophysiology of CDH is a combination of lung hypoplasia and immaturity associated with persistent pulmonary hypertension of newborn (PPHN) and cardiac dysfunction. Prenatal assessment of lung to head ratio (LHR) and position of the liver by ultrasound are used to diagnose and predict outcomes. However, fetal therapy is indicated in cases where negative prognostic factors are detected in screening investigations (liver herniation, LHR <1.0). Immediate management at birth includes bowel decompression, avoidance of mask ventilation and endotracheal tube placement if required. The main focus of management includes gentle ventilation, hemodynamic monitoring and treatment of pulmonary hypertension followed by surgery. Although inhaled nitric oxide is not approved by FDA for the treatment of PPHN induced by CDH. Surgical treatment of CDH should be planned in election, after the achievement of hemodynamic stability. The only case in which it is acceptable to perform an emergency operation is when there are signs of ischemia of the herniated intestinal loops. Extracorporeal membrane oxygenation (ECMO) is typically considered after failure of conventional medical management for infants ≥ 34 weeks' gestation or with weight > 2 kg with CDH and no associated major lethal anomalies. Prematurity, associated abnormalities, severity of PPHN, type of repair and need for ECMO can affect the survival of an infant with CDH. With advances in the management of CDH, the overall survival has improved.

**Keywords:** lung hypoplasia, pulmonary hypertension, extracorporeal membrane oxygenation, prenatal diagnosis

### **1. Introduction**

Congenital diaphragmatic hernia (CDH) is a congenital malformation of diaphragm, which leads to a defect in separation between the thoracic and abdominal cavities [1, 2]. It appears to be due to an error in the development of the pleuro-peritoneal canals and therefore develops around 6 weeks of gestation [1]. Its incidence is 1:3000 live births. Progress in the management of these patients has significantly increased survival rates (up to 90% [3]), but disease-related morbidity remains

very high: the main problem is the compression exerted by the herniated viscera on the developing lungs, development, which causes pulmonary hypoplasia and hypertension [4].

### **2. Classification**

CDH can be classified, depending on the location of the defect, into posterolateral, or Bochdalek's hernia (70–75%), anterior or Morgagni's hernia (23–28%) and central or hiatal hernia (2–7%) [4]. Morgagni's hernia is often discovered incidentally in older children, as it rarely causes such a mass effect on the thoracic level as to compromise the development of the lungs. Bochdalek's hernia is the form that is classically referred to when talking about this pathology and to which we will refer accordingly in the next paragraphs (26). Most often it is located on the left side (85%), but it can also be right (13%) or bilateral (2%) [4].

### **3. Pathogenesis**

The pathogenesis of CDH is complex and currently still little known. Some studies have shown that pulmonary hypoplasia in these patients arises before the development of the diaphragm itself. This discovery opened the door to the so-called "double hit theory" which sees pulmonary hypoplasia as the result of two insults: the first, affecting both lungs, would be due to genetic and environmental factors (for example alcohol, smoking, obesity, low intake of retinoids during pregnancy); the second, which would affect only the lung ipsilateral to the defect, would consist of the compressive effect of the herniated viscera and their interference with normal fetal respiratory movements. Multiple studies have demonstrated the importance of the genetic component in the pathogenesis of ECD: they often fall within syndromic pictures, and about 40% of cases are associated with other congenital anomalies, especially cardiovascular (11–15% of ECD) [4].

### **4. Antenatal management**

Given the potential severity of the disease, prenatal counseling represents a fundamental phase of the diagnostic-therapeutic process of CDH: parents must be adequately informed about all the steps to be taken and the risks in terms of mortality and morbidity.

### **4.1 Antenatal diagnosis**

Ultrasound currently represents the gold standard in CDH diagnosis, although it has been calculated that less than two-thirds of CDHs are detected on prenatal screening ultrasound scans. The mean gestational age at diagnosis is 24–25 weeks, more advanced in cases of isolated defects than in CDHs associated with other anomalies. The typical ultrasound sign is the presence of abdominal organs (intestinal loops, stomach, liver) in the chest. Indirect signs of CDH can be changes in the heart axis, polyhydramnios, mediastinal shift. The differential diagnosis includes all congenital pulmonary malformations, bronchial atresia, intestinal duplications and mediastinal

### *Prenatal Diagnosis of Diaphragmatic Hernia DOI: http://dx.doi.org/10.5772/intechopen.104103*

masses [5, 6]. The execution of genetic tests and second-level imaging tests is essential for defining the prenatal management strategy, whether it is inclined towards termination of pregnancy, or whether it is oriented towards fetal therapies. One of the main prognostic factors is represented by the lung to head ratio (LHR), which by measuring the length of the lung contralateral to the hernia normalized for the head circumference, provides an indirect estimate of pulmonary hypoplasia. More specifically, since the LHR changes with advancing gestational age, we prefer to use the ratio between observed LHR and expected LHR (observed/expected LHR or o/and LHR).

One or/and LHR <25% is indicative of severe hypoplasia, while one/and LHR of 25–35% or an LHR of 35–45% with herniated liver are indicative of moderate hypoplasia. In fact, another prognostic factor is represented by the position of the liver: since the liver and the fetal lung are poorly distinguishable ultrasonographically, there may be an indication to perform a fetal magnetic resonance [3–6]. It allows to evaluate not only the presence or absence of liver in the thoracic cavity, but also to quantify the observed/expected total fetal lung volume (or/and TFLV), which was a better predictor in terms of postnatal survival. As an alternative to magnetic resonance evaluation of the or/and TFLV, some authors have demonstrated a close relationship between the liver herniation, the position of the stomach (which being anechoic is much more easily identifiable) and the postnatal outcome. Finally, given the high frequency with which EDC is associated with cardiovascular anomalies, there is an indication to perform fetal echocardiography [7, 8].

### **4.2 Antenatal therapies**

The prenatal management of fetuses affected by CDH essentially provides for an ultrasound monitoring of the ultrasound parameters described above, associated in doubtful cases with second level examinations such as resonance. In recent years, however, fetal therapy has become increasingly popular on the international scene, indicated in cases where negative prognostic factors are detected in screening investigations (liver herniation, LHR <1.0). The purpose of these interventions is essentially to stop the mechanisms that induce the onset of complications such as pulmonary hypoplasia and pulmonary hypertension as early as possible. The technique currently most used is fetal tracheal occlusion (FETO): it is based on the principle that the occlusion of the trachea prevents the leakage of fluids, increasing the pressure in the airways and promoting lung growth. However, animal models have shown that tracheal occlusion reduces the maturation of type II pneumocytes, inducing a surfactant deficiency: for this reason the so-called "plug-unplug" sequence was devised, in which the patency of the trachea is first interrupted by the introduction of a balloon (or plug) and then re-established before delivery to allow lung maturation. This procedure can be performed percutaneously under ultrasound guidance or fetoscopy, typically between 27 and 32 weeks of gestational age, with the plug removed at 34 weeks. This procedure appears to be associated with increased survival in children with moderate and severe CDH, although further risk-benefit studies are certainly needed.

In children with CDH, the only medical treatment for which there is evidence of efficacy is corticosteroid therapy: maternal administration of one or two doses of corticosteroids at 34–36 weeks of gestation appears to be correlated with a reduction in respiratory morbidity at birth. Promising studies are also underway on the prenatal use of retinoids and phosphodiesterase inhibitors (Sildenafil) and on the use of stem cells from amniotic fluid in combination with FETO [4].

### **5. Postnatal management**

The optimal timing and modality of delivery for children with CDH are still under discussion today. There seem to be no indications for induced delivery before 38 weeks of gestation, as well as there do not seem to be any advantages in performing a cesarean section. On the other hand, a unanimous consensus was found on the importance of planning the birth in a third-level center, where a multidisciplinary group (gynecologists, neonatologists, surgeons and pediatric anesthetists) is available, capable of managing the disease [4].

At birth, the main objective must be to ensure adequate ventilatory support (without triggering a vasospasm or further lung damage) and induce not too deep sedation (which would further compromise respiratory function). In case of respiratory distress, endotracheal intubation is carried out directly: in fact, ventilation with a facial mask must be avoided, as it would lead to distension of the stomach and intestinal loops, worsening the respiratory dynamics.

For the same principle, the positioning of a nasogastric tube is indicated at the same time, in order to decompress the stomach as much as possible. It is considered acceptable to maintain reduced saturation levels and a certain degree of hypercapnia, as long as the pH is kept above 7.2: in the presence of acidosis, in fact, vascular resistance would increase and consequently the risk of pulmonary hypertension. Another major problem in these patients is hemodynamic instability: to assess the need for inotropic support, these patients must be continuously monitored from a pressure point of view and postnatal echocardiography (within 48 h of life) must be performed if necessary repeated at 2–3 weeks. The indication for the ECMO, as a bridge to surgery in the most compromised patients, is still much debated. One of the biggest challenges remains the management of pulmonary hypertension: currently the most widely used treatment is inhaled nitric oxide, although encouraging new studies are underway on the use of Sildenafil [2, 4, 5].

Surgical treatment of CDH should be planned in election, after the achievement of hemodynamic stability. The only case in which it is acceptable to perform an emergency operation is when there are signs of ischemia of the herniated intestinal loops. As for the surgical technique, this can be performed openly (in thoracotomy or laparotomy) or by minimally invasive techniques. The intervention consists in the repositioning of the herniated organs within the abdomen and consequently in the closure of the defect, which can be primary or with a patch depending on the size of the defect. Minimally invasive techniques and the use of a patch were associated with a higher relapse rate [3, 4].

### **6. Long-term outcomes**

In light of the increased survival of newborns with CDH, long-term outcomes, especially in terms of quality of life, have assumed increasing importance over time. The most compromised organs are certainly the lungs: in addition to the well-known pulmonary hypertension, these children experience alterations both in a restrictive sense (due to pulmonary hypoplasia) and in an obstructive sense (similar to bronchodysplasia of the premature infant) [8]. Pulmonary function seems to gradually restore during childhood, but recent studies have shown a slight deterioration of the same from childhood to adulthood. The respiratory system is not the only one affected by

### *Prenatal Diagnosis of Diaphragmatic Hernia DOI: http://dx.doi.org/10.5772/intechopen.104103*

this disease. Gastroesophageal reflux is present in 45–89% of children with CDH and appears to be correlated with the size of the defect. Stunted growth is also a frequent finding, affecting 69% of these children at 1 year of age. Neurological alterations (in terms of delay in neurodevelopment but also sensorineural deafness) represent one of the most feared and also most frequent complications of CDH, with incidence rates ranging from 12 to 77%, especially in children undergoing ECMO. Finally, musculoskeletal deformities (chest anomalies, hemithorax asymmetries, scoliosis) were reported in 21–48% of patients treated for CDH [3].

All this, together with the fact that a good percentage of CDHs fall into syndromic pictures or are associated with other congenital anomalies, justifies the importance of a long-term follow-up program.

### **Author details**

Marina Sica\*, Carlotta Plessi and Francesco Molinaro University of Siena, Italy

\*Address all correspondence to: sicamarina121@gmail.com

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

### **References**

[1] Lima M, editor. Pediatric Thoracic Surgery [Internet]. Mailand: Springer-Verlag; 2013 [cited 2021 Mar 27]. Available from: https://www.springer. com/gp/book/9788847052017

[2] Dingeldein M. Congenital diaphragmatic hernia. Advances in Pediatrics. 2018;**65**(1):241-247

[3] Leeuwen L, Fitzgerald DA. Congenital diaphragmatic hernia: Congenital diaphragmatic hernia. Journal of Paediatrics and Child Health. 2014;**50**(9):667-673

[4] Bloss RS, Aranda JV, Beardmore HE. Congenital diaphragmatic hernia: Pathophysiology and pharmacologic support. Surgery. 1981;**89**(4):518-524

[5] Kirby E, Keijzer R. Congenital diaphragmatic hernia: Current management strategies from antenatal diagnosis to long-term follow-up. Pediatric Surgery International. 2020;**36**(4):415-429

[6] Cordier A-G, Russo FM, Deprest J, Benachi A. Prenatal diagnosis, imaging, and prognosis in congenital diaphragmatic hernia. Seminars in Perinatology. 2020;**44**(1):51163

[7] Kitano Y. Prenatal intervention for congenital diaphragmatic hernia. Seminars in Pediatric Surgery. 2007;**16**(2):101-108

[8] Nakajima Y, Einspieler C, Marschik PB, Bos AF, Prechtl HFR. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally? Early Human Development. 2006;**82**(1):53-59

### **Chapter 7**

## Fetal Craniospinal Malformations: Aetiology and Diagnosis

*Artur Beke, Virág Bartek and Aténé Simonyi*

### **Abstract**

The chapter discusses the aetiology and diagnostics of each fetal craniospinal disorder, particularly neural tube defects, ventriculomegaly, Dandy-Walker and Arnold-Chiari malformation, corpus callosum dysgenesis, iniencephaly, holoprosencephaly, microcephaly and kinked-brainstem. We aimed to highlight the usual ultrasound findings and genetic testing options.

**Keywords:** neural tube defects, anencephaly, exencephaly, spina bifida, ventriculomegaly, encephalocele, hydrocephalus, Dandy-Walker, Arnold-Chiari, corpus callosum, iniencephaly, kinked-brainstem, holoprosencephaly, microcephaly

### **1. Introduction**

Our knowledge of the genetic background of the development of neurodevelopmental disorders is evolving. Today, ultrasound is a gold-standard diagnostic method for diagnosing developmental disorders. In addition to teratogenic causes, an increasing genetic background is being recognised for more and more fetal disorders. In addition to ultrasound diagnostics, the aim of this chapter is to investigate the genetic diagnostics of developmental disorders affecting the nervous system. In the case of malformations involving multiple organ systems, we investigate what chromosomal abnormalities or gene mutations may underlie each multiple disorder.

### **2. Fetal craniospinal malformations**

### **2.1 Neural tube defects. Anencephaly/exencephaly. Spina bifida. Encephalocele**

### *2.1.1 Epidemiology*

Neural tube defects are the second most common structural-developmental malformations [1]. If the failure of neural tube closure is at the cranial end of the developing embryo, the disorder occurs in the form of anencephaly (initially exencephaly), if the failure is more caudal than cranial, it occurs in the form of spina bifida.

The prevalence of neural tube defects (NTDs) is 0.5–2/1000 live births, showing a heterogeneous geographical and ethnic distribution [2]. A genetic cause can be identified in 20% of cases [3].

### *2.1.2 Fetal morphology and prognosis*

The brain of an anencephalic fetus is missing or missing in large parts. The form localising only to the cranium is called meroacrania, and extending to the foramen magnum is called holoacrania. If the spinal cord is also affected, the disorder is called craniorachischis.

The most severe neural tube closure disorder is caused by abnormal closure of the cranial section of the neural tube [4]. Anencephaly is a condition incompatible with life.

Spina bifida develops due to an abnormality in the closure of the neural tube caudally from the cranium. It basically affects the spinal region, with or without nerve tissue involvement. Its mildest form is spina bifida occulta, which is a defect of the vertebral arcs without affecting the underlying nerve tissue, most commonly in the sacral region, and usually causes no symptoms. In the case of spina bifida cystica, the lesion advances cystically. It can be closed (covered with skin or an opaque membrane) or open. If the cyst has meninx and cerebrospinal fluid but no nerve tissue in it, the lesion is called meningocele, if it also contains nerve tissue elements, the term is myelomeningocele [5]. The most severe form is myeloschisis (also known as rachischisis), which is an open lesion, so nothing covers the medullary (neural) plate [5]. After birth, spina bifida occulta usually does not cause symptoms, while spina bifida cystica can lead to paralysis of the lower extremities and urinary problems. Although myelomeningocele is a developmental disorder compatible with life, it is often associated with varying degrees of disability.

In encephalocele, the brain tissue with or without the meninges protrudes hernialike through a pathological opening in the skull [5]. The most common site of its formation is os occipital [6]. Based on the grouping of Suwanwela and Suwanwela: cranial, frontoethmoidal, and basal encephalocele can be distinguished in addition to the occipital group [7].

### *2.1.3 Aetiology*

To date, no clear genetic defect has been identified in the background of the development of NTDs, however, the role of a number of environmental and genetic predisposing factors is already known. It has been clinically demonstrated that folic acid supplementation significantly reduces the incidence of neural tube defects during the first trimester of pregnancy. Folic acid enrichment of the flour reduced the incidence of NTDs by 18% in 59 countries [8]. Folic acid, which is involved in purine and pyrimidine synthesis, is one of the cornerstones of DNA synthesis. Of course, not only isolated folic acid deficiency but any drug involved in folic acid synthesis may be associated with the development of anencephaly and other neural tube defects. These drugs such as antiepileptics (valproate or carbamazepine) and antimalarials (trimethoprim) are contraindicated during pregnancy without adequate folic acid supplementation, especially, in the first trimester.

In 1999, Shields et al. identified a heat-labile *MTHFR* C677T mutant gene that was present in the homozygous form of TT in 51 (18.8%) of 271 infants with neural tube defects (the homozygous form of CC did not increase the rate, whereas the heterozygous form of CT alone non-significantly increased the incidence of neural tube defects) [9].

Two members of the *SHROOM* gene family, the *SHROOM*-*2* and *SHROOM-3* genes have also been associated with the development of NTDs.

The role of the *SHROOM-3* gene in complex morphogenesis has long been demonstrated, and a mutation in a Loss of Function (LoF) (p.N594f) may be

associated with the development of neural tube defects. The Shroom-3 protein encoded by the gene is involved in the planar cell polarity (PCP) pathway, and in animal models, it has been found that its main function is to regulate the distribution of myosin II in cells [10].

A Chinese research team, Z. Chen et al. isolated 1.56 times as many rare variants in the *SHROOM-3* gene in live-born children with NTD than in the control group. In addition, the same research has also linked another member of the *SHROOM* family, the *SHROOM-2* gene mutation, to the development of neural tube defects. *SHROOM-2* is a gene localised on the short arm of the X chromosome (Xp22.2), which encodes a protein of the same name, Shroom-2. Shroom-2 is expressed by endothelial cells; its role in facilitating the development of the contractile network in endothelial cells. In infants with NTD cases, 4.5 times as many deleterious missense (D-Mis) variants were identified compared with the control group. In the same study, *SHROOM-2* variants were found in 42 of the 343 NTD cases, of which 15 mutations were identified. More than one *SHROOM-2* mutation was found in five of these samples [1].

Because the convergent extension is a critical point in neural tube closure, mutation of the gene encoding any other protein in the PCP system that regulates it leads to neural tube closure disorders. Mutation of PCP core genes such as *VANGL2* or *CELSR1* has been shown in mouse models to lead to the development of severe NTDs [11]. It is likely that genes encoding other proteins involved in the PCP signalling pathway may also be associated with neural tube closure disorders, however, human orthologs of the genes found in the experimental models have not yet been identified, so this may be part of further research.

Foetuses of untreated diabetic mothers are also more prone to neural tube defects, as elevated blood glucose levels lead to misfolded proteins, their accumulation and apoptosis of cells through non-enzymatic glycosylation.

This causes structural damage to organogenesis, especially the neuroepithelium. In animal models, high-dose folic acid supplementation has also been shown to reduce the incidence of neural tube defects associated with high blood glucose [12]. In terms of other environmental factors, hyperthermia and vitamin A deficiency may also lead to NTD, the former due to heat stress and the latter due to its role in the retinoic acid pathway resulting in the inadequate closure of the neural tube. Maternal obesity increases the chances of developing NTDs through hyperinsulinemia, and metabolic syndrome through its teratogenic effect due to oxidative stress [13].

### *2.1.4 Diagnostics*

Anencephaly can be diagnosed in the first trimester (in this case, exencephaly is shown in the image), but can only be diagnosed with ultrasound in the second trimester with high certainty, median time to prenatal diagnosis is 20 weeks (16–24) [14]. Ultrasound signals that the upper part of the skull is missing and that no parenchymal tissue can be detected in the skull, however, the brainstem and occipital bone can be identified. In the coronal plane, a 'frog eye' or 'Mickey Mouse' symptom is seen, which is due to a lack of cranial bones and a protruding bulbus. In some cases, it is associated with polyhydramnios, which is the result of insufficient amniotic fluid ingestion by the fetus.

Spina bifida can be diagnosed in the second trimester, with a median time of 21 weeks (18–24). The time and accuracy of detection depend largely on the type of spina bifida and the position of the fetus, as certain positions make it very difficult to follow the spinal column. The direct signs are the openness of the vertebral arches and herniation of the spinal cord, and the indirect signs are the lemon sign, the biconcave os frontale, and the banana sign, which is an abnormally bent, thin shape of the cerebellum. Ventriculomegaly due to cerebrospinal fluid flow disturbance is also common in foetuses with spina bifida, however, this ultrasound signal is not specific for diagnosis. Furthermore, the clivus-supraocciput angle is of diagnostic value; if it is less than 5 percentile, it raises the possibility of a form of neural tube defect associated with Chiari II malformation [15].

Thanks to modern technology, the availability of 3D and 4D ultrasound and MRI make it easier to diagnose neural tube defects so that in case of doubtful ultrasound findings, the diagnosis can be clarified by choosing another imaging modality. However, it should be noted that although these tests are much more accurate than conventional transabdominal and transvaginal ultrasound, their cost and limited availability make it essential to perform 2D ultrasound accurately and precisely, as it is still the most accessible, quickest and most economical method of diagnosis today.

In addition to imaging, laboratory tests can also support the diagnosis, as in 90% of cases, α-fetoprotein (AFP) levels are elevated in maternal blood and amniotic fluid, so this may be an additional tool to imaging. However, with the development of ultrasound, this test has been superseded.

In about one-tenth of cases, a chromosomal aberration or mutation has been identified as the cause of the neural tube defect, i.e., the majority of NTDs have a non-syndromic cause [16]. It can be seen that, although no clear environmental influence or genetic mutation has been identified as the cause of NTDs, it is likely that their development is multifactorial, i.e., genetic predisposing factors and environmental stresses contribute to their development.

### *2.1.5 Postnatal morphology and associated disorders*

Postnatally, the anencephalic infant lacks a cranial bone (skull), the cerebellum is only a mass, shrunken. The ears are low set and deformed. Facial structures such as the eyes, nose and cheeks are large. The neck is short and spinal abnormalities may be present. The limbs are deformed, the thymus is abnormally large and pulmonary hypoplasia is often present. Spina bifida may be present with minimal external signs depending on the severity of the disease (in spina bifida occulta, only a darker patch or patch of hair-covered skin in the sacral region indicates a malformation). Depending on the region affected, a child with spina bifida lacks the structures covering the spinal column at the affected vertebrae and may have a herniated spinal cord; in meningocele and myelomeningocele, the protruding cyst is visible in the occipital region, with or without nerve tissue.

Neural tube defects are most commonly associated with renal abnormalities such as hydronephrosis, polycystic kidney disease, uni- or bilateral agenesis or unilateral hypoplasia. Cardiac malformations range from simple septal defects to complex cardiac malformations [17].

### **2.2 Congenital ventriculomegaly and hydrocephalus**

### *2.2.1 Epidemiology*

Ventriculomegaly is one of the most common pathological findings during antenatal ultrasound screening [18]. In severe cases, we are talking about hydrocephalus. The prevalence of hydrocephalus is 11/1000 live births [19].

### *2.2.2 Fetal morphology and prognosis*

Hydrocephalus develops due to a progressive increase or impaired absorption of intraventricular cerebrospinal fluid (CSF) and its pathomechanism can be either obstructive or communicating [17, 20]. Increased pressure leads to the dilation of the ventricles, i.e., ventriculomegaly. If the brain volume thins due to the growth of the ventricles, we speak of hydrocephalus internus, if the volume of cerebrospinal fluid increases in the subarachnoid spaces, we speak of hydrocephalus externus. Macrocephaly can also develop with the growth of the bony skull [5], and the skull of such a fetus is larger than average.

The CSF is produced by the choroid plexus, circulates in the ventricles, then exits through the fourth ventricle into the subarachnoid space, where it is absorbed by the granulationes arachnoideae and finally drained through the venous sinuses into the systemic circulation. 1/3 of the CSF enters the lymphatic circulation, however, pathological alterations of this have not yet been demonstrated in human models [19].

The prognosis of hydrocephalus depends on its severity and the success of prenatal treatment. Of the 90 cases of hydrocephalus followed up by Yamasaki et al., 17% resulted in death, 21% were diagnosed with severe retardation, 13% with moderate retardation and 26% with mild retardation. A normal phenotype was described in 23% of cases [21].

The classification of ventriculomegaly depends on the degree of dilatation detected on ultrasound: mild ventriculomegaly between 10−12 mm, moderate ventriculomegaly between 13−15 mm and severe ventriculomegaly above 15 mm. The measurement is taken at the atrium of the lateral ventricle, the point where the temporal and posterior horns converge. This is a fixed value between 15 and 40 weeks of pregnancy [22].

If no abnormality is found in genetic testing and no other associated abnormality is present, mild ventriculomegaly is not considered pathological, and postnatally 90% of these cases present a normal phenotype, i.e., the wider ventricle is considered a normal variant [22].

### *2.2.3 Aetiology*

Congenital hydrocephalus can be syndromic or non-syndromic, but in half of the cases, it is idiopathic [20]. The most common form of congenital hydrocephalus is the X-linked monogenic *L1CAM* mutation. The gene product of *L1CAM* is a protein that plays a key role in neuronal migration.

Hydrocephalus due to the *L1CAM* mutation is one of the most severe forms associated with stenosis of the aqueduct of Sylvius, known as HSAS (Hydrocephalus with Stenosis of the Aqueduct of Sylvius). It is often associated with corpus callosum agenesia or hypoplasia, adducted thumb and other structural cerebellar abnormalities [20]. Another form of X-linked congenital hydrocephalus is associated with *AP1S2* mutation [23].

Mutations in the *MPDZ* gene lead to primary ependymal malformations, including hydrocephalus [20]. *MPDZ* encodes a protein that regulates tight junction function and is also likely involved in the PCP pathway [24]. Mutations in this gene at 9p23 lead to autosomal recessive non-syndromic hydrocephalus [25]. Another form of autosomal recessive hydrocephalus is caused by mutations in *CCDC88C*. This gene encodes a protein called Daple, which interacts with Dishevelled protein to regulate cell migration. The Dishevelled protein is a member of the non-canonical Wnt pathway [26].

In addition to these well-studied genes, two others have recently been identified that are associated with the development of hydrocephalus. The *EML1* gene (14q32.2) encodes a microtubule system-related protein that is also involved in the PCP pathway. The gene mutation results in abnormal development of the posterior part of the skull, leading to severe hydrocephalus [23]. Also in this study, Shaheen et al. described another mutation, *WDR81* (17p13.3), which leads to severe hydrocephalus with cerebellar hypoplasia.

Neural tube defects are often associated with hydrocephalus. This may be due to common genetic factors and environmental aetiology, and pathological spinal development may itself be a physical barrier to CSF. Arachnoid cysts may also form a physical barrier in the pathway of cerebrospinal fluid. As arachnoid cysts occur in 15% of Phelan-McDermid syndromes, this syndrome is also often associated with hydrocephalus [19]. Other syndromes include mucopolysaccharidosis, Sotos syndrome and Rothmund-Thomson syndrome. Cytogenetic abnormalities have also been associated with the disorder, such as microdeletion of 9q22.3, partial trisomy of chromosome 1, but hydrocephalus is also common in Patau, Edwards and Down syndromes [19].

Ventriculomegaly/hydrocephalus may occur in isolated cases as a consequence of TORCH (Toxoplasma, Rubeola, Cytomegalovirus, Herpes simplex and other viruses) infection during pregnancy, or in rare cases due to congenital tumours such as choroid plexus papilloma [21].

### *2.2.4 Diagnostics*

In terms of ultrasound diagnostics, it should be noted that in the first trimester, physiological ventricular dilatation is present, so hydrocephalus can only be diagnosed with certainty after the 14th week. The first characteristic ultrasound sign is asymmetry of the choroid plexus [27]. The top of the fourth ventricle may show an abnormal image and the absence of foramina Magendii and Luschka is common [17]. Due to the progressive nature of hydrocephalus, it may develop throughout pregnancy and even after birth without any previous ultrasound signal. Thus, the time to diagnosis also varies widely; Yamasaki et al., in their study of 156 cases of hydrocephalus, found the diagnosis to be made between 13 and 40 weeks (51% of cases were already diagnosed before 28 weeks). Breeze et al., also reported similar data, with a median time to diagnosis of 28 weeks (16–36) [28].

In addition to ultrasound, if ventriculomegaly or hydrocephalus is suspected, a Magnetic Resonance Imaging (MRI) scan may be useful, as it is a more accurate and reliable way of showing the development of brain structures and their possible malformations than ultrasound. However, it should be taken into account that, in addition to the general disadvantages of MRI (difficult availability, high costs), the fact that the fetal movement makes the findings more difficult or impossible to evaluate in antenatal diagnosis is a particular difficulty [29].

### *2.2.5 Postnatal morphology and associated disorders*

The neonate with ventriculomegaly/hydrocephalus has macrocephaly, which may progress postnatally [30]. The disorder is often associated with neural tube defects due to common genetic predisposing factors.

### **2.3 Dandy-Walker malformation**

### *2.3.1 Epidemiology*

The incidence of this malformation is 0.33/1000 live births [31], i.e., it is a relatively rare disorder.

### *2.3.2 Fetal morphology and prognosis*

The Dandy-Walker malformation includes dilatation of the fourth ventricle with hypoplasia or agenesis of the vermis of the cerebellum. A pseudocyst often develops at the base of the posterior fossa. Survival is low (about half of cases) [5].

### *2.3.3 Aetiology*

Genetically heterogeneous in origin, several mutations have been described in recent years. However, one of the main "suspects" are the *ZIC1* and *ZIC4* genes, located at 3q24. In terms of inheritance, autosomal dominant, recessive and X-linked inheritance patterns have been reported, so it may be present as part of trisomy 9 (AR) or 6p (AD), but it may also be associated with Aicardi syndrome.

It is common in Edwards syndrome. However, in addition to genetic causes, a number of environmental factors may contribute to its development, such as maternal alcoholism or severe diabetes mellitus, as well as TORCH infection in the first trimester [17].

### *2.3.4 Diagnostics*

Dandy-Walker malformation can be diagnosed by ultrasound at the earliest at week 11, but it should be noted that isolated dilatation of the fourth ventricle may be physiological during early development. In addition, the cerebellar vermis is not fully developed until the second trimester. In conclusion, an accurate diagnosis is only possible during the second trimester [27].

### *2.3.5 Postnatal morphology and associated disorders*

Since the disorder mainly affects the cerebellum, in case of survival, postnatally the disorder may be marked by muscle movement disorders, learning difficulties and mental retardation. Hydrocephalus and consequent macrocephaly often develop due to inhibition of cerebrospinal fluid drainage [17]. It is often associated with hyperdactyly, syndactyly, renal, hepatic and pancreatic alloplasia and abnormal retina [32].

### **2.4 Arnold-Chiari malformation**

### *2.4.1 Epidemiology*

There are four types of Arnold-Chiari syndrome. Its prevalence is 0.9/1000 live births [33].

### *2.4.2 Fetal morphology and prognosis*

In type I, the cerebellar tonsils are ectopic, with a part of the tonsils pressing into the foramen magnum, often in isolation. In type II, there is cerebellar hypoplasia with myelomeningocele, part of the tonsils and the elongated distal part of the brainstem protruding into the foramen magnum. In type III, the cerebellum is herniated due to the absence of occipital bone and spina bifida. In type IV, the most severe type, the cerebellum itself is hypoplastic [17]. Structural deformities lead to hydrocephalus. A lesion with a poor prognosis.

### *2.4.3 Aetiology*

In the majority of cases, Arnold-Chiari malformation is multifactorial, and external environmental factors may also play a role in the development of the disease.

A precise genetic mutation has not yet been identified. It is assumed to be the result of mutations in proteins involved in the Sonic hedgehog and Wnt pathways, suggesting that there is an overlap at the gene level between mutations causing neural tube defects and Arnold-Chiari malformation, but this requires further research. Its aetiology is probably multifactorial and it cannot be ruled out that various environmental factors also contribute to the development of the phenotype.

Syringomyelia is often described in this pathology. In syringomyelia, the cavity formation observed in the nervous system may be due to residual formations from embryonic age, but may also occur as a result of haemorrhage or inflammation.

### *2.4.4 Diagnostics*

An ultrasound scan in the second trimester of pregnancy can raise suspicion of the lesion, and if necessary, an MRI scan can confirm the diagnosis.

### *2.4.5 Postnatal morphology and associated disorders*

Type I occurs in 3–5% of patients with Klippel-Feil syndrome, suggesting that abnormal *GDF6* and *GDF3* function may also be associated with the development of the syndrome [33].

Syringomyelia, which is often associated with type II, is rarely hereditary and may be associated with the following additional pathological conditions and gene mutations: hydrocephalus (*NF1, NES, GFAP, FGFR2, AQP4*), spina bifida (*GDF6*, *GDF3*) and other spinal deformities (*VDR, POC5, NF1, GH1, GFAP, GDF3*), various neurological tumours: astrocytoma (*NRAS, NF1, NES, GFAP, COL1A1*), neurilemmoma (*NF1, NES, GFAP*), ependymoma (*NES, GFAP*).

In addition, syringomyelia may also be caused by tissue weakness, such as in Ehlers-Danlos syndrome (mutations in *COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, TNXB, ADAMTS2, PLOD1, B4GALT7, DSE, D4ST1/CHST14* genes) or Marfan syndrome (mutation in *FBN1* gene).

### **2.5 Corpus callosum agenesia/dysgenesis**

### *2.5.1 Epidemiology*

The prevalence of malformations of the corpus callosum is 0.25/1000 live births. In terms of aetiology, 30−45% of cases are due to genetic causes, 10% to chromosomal abnormalities and 20−35% are associated with a genetic syndrome. In some cases, environmental factors (e.g., maternal alcohol consumption) also lead to corpus callosum dys- or agenesis [34].

### *2.5.2 Fetal morphology and prognosis*

The corpus callosum is one of the five major cerebral commissures and is one of the largest white matter-containing tract in the brain. Its role is to connect the right and left hemispheres of the brain, and it is thought that 2−3% of the cortical fibres are passing through it. Its main function is to coordinate the hemispheres of the brain and to integrate sensory and motor functions [35].

Isolated corpus callosum dys- or agenesis is a disorder compatible with life, however, approximately 25% of foetuses with isolated corpus callosum agenesis/ dysgenesis diagnosed antenatally will later have an intellectual disability. In addition, mild social or learning deficits may occur even with normal intelligence [35]. If the developmental disorder is part of a syndrome, the outcome of the disease depends on the particular syndrome.

### *2.5.3 Aetiology*

Known chromosomal abnormalities affect chromosomes 1, 4, 6, 8 and 17. The most common type is a deletion, including the 1q42-q44 deletion causing corpus callosum dys- or agenesis of variable severity [35]. As most of the proteins encoded by these regions regulate or are involved in a key moment in nervous system development, corpus callosum dys- or agenesis as an isolated developmental disorder does not occur in any of the chromosomal disorders, but is often associated with microcephaly, hydrocephalus or craniofacial abnormalities.

Inheritance patterns include autosomal dominant, recessive and X-linked hereditary syndromes.

A very severe form of X-linked dominant (XLD) inheritance is Aicardi syndrome, which is incompatible with life in male foetuses but also has high premature mortality in girls. In addition to corpus callosum agenesis, it is associated with infantile seizures (infantile spasm) and the development of chorioretinal lacunes [36].

The autosomal dominant form is frontonasal dysplasia, Goldenhar syndrome; autosomal recessive form is Andermann syndrome, craniotelencephalic dysplasia, Da Silva or Leigh syndrome. Isolated corpus callosum dys- or agenesis can be inherited in an autosomal recessive, X-linked recessive (XLR) or autosomal recessive (AR) manner [17].

### *2.5.4 Diagnostics*

Developmental abnormalities of the corpus callosum are difficult to detect before 18 weeks [35]. Ultrasonography shows colpocephaly, a high-lying enlarged third ventricle with absent or abnormal morphology of the corpus callosum [34]. These may confirm the suspicion, as in ultrasound diagnostics there is always the question of whether the absence of a formula is not only due to the position of the fetus, or possibly to a technician error. In their 2012 study, Santo et al. found that the number of false-positive ultrasound findings can be as high as 20%. An MRI scan after 22 weeks can confirm or refute the ultrasound findings with high certainty [37].

### *2.5.5 Post-natal morphology and associated abnormalities*

Corpus callosum dys- or agenesis is often associated with microcephaly, hydrocephalus or craniofacial abnormalities [17]. Therefore, both the postnatal picture and the associated abnormalities are influenced by the gene mutation that results in the disorder.

### **2.6 Holoprosencephaly**

### *2.6.1 Epidemiology*

Holoprosencephaly is a midline malformation of the cranium and face. Its prevalence is estimated to be between 0.2 and 0.06 per 1000 live births [17, 38].

### *2.6.2 Fetal morphology and prognosis*

The three main types of holoprosencephaly are lobar, semi-lobar and alobar. The most severe form is alobar, where midline separation is completely absent and the blister of the telencephalon does not separate. Typically, the corpus callosum and the third ventricle are absent, and cyclopia and proboscis are present. In the semilobar form, the frontal and parietal lobes are usually not separated bilaterally, but all septations, especially in the posterior region, are observed. Microphtalmia or anophtalmia, nasal malformations may also be associated. In the least severe form, the lobar form, the two hemispheres are essentially retained, with varying degrees of fusion between the two halves. The nose may be depressed with eyes sitting close, but the facial phenotype may be completely normal [39].

The prognosis depends on the severity of the holoprosencephaly. Mortality is high in alobar cases.

### *2.6.3 Aetiology*

As with all neural tube defects, the development of holoprosencephaly is multifactorial, with both genetic and environmental influences contributing to its occurrence [40].

It is often associated with chromosomal abnormalities, most commonly with trisomy (Patau syndrome) or deletion of chromosome 13, but may also be associated with trisomy and deletion of chromosomes 18 and 21. Monogenic syndromes have also been associated with foetuses with holoprosencephaly, such as ARH (autosomal recessive holoprosencephaly), ADH (autosomal dominant holoprosencephaly), Váradi-Papp syndrome (AR), Grote syndrome (AR), Steinfield syndrome (AD) or holoprosencephaly-fetal akinesia syndrome (XL) (Wainwright, 2005). Environmental influences have also been implicated in the development of holoprosencephaly, such as maternal alcohol consumption during pregnancy and insulindependent diabetes mellitus.

A clear genetic mutation has been identified in the background of 15−20% of holoprosencephalic disorders [41]. Since the Sonic hedgehog signalling pathway is responsible for the regulation of the ventral phase of nervous system development and for the separation of the brain vesicles, it is understandable that genes affecting this mutation and their dysfunctional protein products would also be involved in this pathway. Mutations in the *SHH* gene itself have been demonstrated to underlie

### *Fetal Craniospinal Malformations: Aetiology and Diagnosis DOI: http://dx.doi.org/10.5772/intechopen.103691*

holoprosencephalic retardation since 1996 [42]. Later, mutations in several members of the signalling pathway were identified, including mutations in *PTCH1* and *GLI2*. The Six-3 protein has not yet been linked to any of the signalling pathways, but mutations in *SIX3* are responsible for about 1.3% of holoprosencephaly cases. Six-3 is thought to play a role in the Wnt pathway [43].

There are also correlations between the development of neural tube defects and holoprosencephaly due to their common predisposing factors. K. Shiota found 14 cases of exencephaly or myeloschisis in 150 embryos with holoprosencephaly, but no correlation was found between holoprosencephaly and the severity of the neural tube defect. Diabetic mothers have a higher risk of developing both holoprosencephaly and neural tube defects [41].

### *2.6.4 Diagnostics*

It can be diagnosed prenatally by transabdominal or transvaginal ultrasound, however, some of the milder lobar forms are difficult to diagnose by ultrasound. The median time to diagnosis of holoprosencephaly is 12 weeks (10–14) [27]. In the alobar type, morphological abnormalities of the face (cyclopia, ethmocephaly, cebocephaly) and absence of the choroid plexus in the lateral ventricles are well diagnosed by ultrasound. Dorsal cysts, ventriculomegaly and absence of the cavum septum pellucidum may also be associated findings [44]. An ultrasound sign of semilobar holoprosencephaly is incomplete separation of the hemispheric nuclei and fused thalamus. Both types are often associated with polydactyly, renal dysplasia, omphalocele and hydrops [44].

### *2.6.5 Postnatal morphology and associated disorders*

Kaliaperumal et al. found a 95% mortality rate in alobar holoprosencephaly after antenatal diagnosis. Even mild cases are associated with severe postnatal complications, often requiring neurosurgery and intensive care [45].

### **2.7 Microcephaly**

### *2.7.1 Epidemiology*

Microcephaly is a deviation of at least three standard deviations of head circumference from the mean for given sex and age at fetal maturity [46]. A microcephaly finding is a clinical finding in itself, not a diagnosis [47]. Primary microcephaly is defined as a diagnosis made before 36 weeks of gestation, secondary microcephaly develops after birth [47]. The incidence of primary microcephaly is 0.16–0.025/1000 live births [17].

### *2.7.2 Fetal morphology and prognosis*

Primary microcephaly is a static condition [48]. Phenotypic microcephaly is associated with varying degrees of cognitive deficits depending on the mutation, in addition, to head circumferential abnormalities, but weight, height and other external variations are not common. Imaging studies show normal brain morphology [48]. The prognosis depends on the type of mutation and is generally good, but in the majority of cases, severe deterioration in the quality of life is to be expected.

### *2.7.3 Aetiology*

In terms of aetiology, microcephaly may be caused by a reduction or absence of neurogenesis (due to Cytomegalovirus (CMV) infection, chromosomal abnormality or primary autosomal recessive microcephaly), a prenatal destructive process (e.g., hypoxia, ischaemia) or a rare genetic syndrome.

TORCH infection suffered antenatally, especially in the first trimester, also increases the chance of developing microcephaly [47]. In addition to TORCH pathogens, the Zika virus has received particularly high press coverage in recent years due to the increased number of cases in the US. The association between Zika virus infection during pregnancy and primary microcephaly was quickly shown to be significant. 41,473 pregnant women infected with Zika virus were studied in Brazil between 2015 and 2016. Of these, 1950 cases of microcephaly associated with infection were recorded [49]. The almost 5% case rate is a huge increase compared to the average of 0.02%, and therefore more attention should be paid to mapping the teratogenic effects of Zika virus and preventing infection.

In particular, exposure to harmful substances such as maternal alcohol consumption in the first trimester increases the risk of developing microcephaly in addition to neural tube defects and hydrocephalus. Since fetal hypoxia during pregnancy can also lead to the development of microcephaly, special attention should be paid to pregnant women with placental insufficiency [47].

Isolated microcephaly is an autosomal recessively inherited disorder. Its pathomechanism is a disorder of neurogenic tissue mitotic activity, with normal cell migration and apoptosis [48]. Currently, 18 genes have been identified in the pathogenesis of primary microcephaly. All are members of the MCPH (autosomal recessive primary microcephaly) gene family.

In addition to the autosomal recessive form, mutations in other gene families are known to lead to primary microcephaly. These include *KIF2A, KIF5C* and *KIF11* from the kinesin family, and *TUBG1*, *TUBB2B* and *TUBA1A* from the tubulin family. The proteins encoded by these genes also contribute to the physiological function of the microtubule system.

Among chromosomal abnormalities, microcephaly is often associated with Patau, Edwards and Down syndromes [17].

### *2.7.4 Diagnostics*

Ultrasound diagnosis is made by calculating the head circumference, calculated from the biparietal diameter and the occipitofrontal diameter. This derived value is compared with the mean value for the developmental stage and sex, and if it is at least two [50], in other sources three [46], standard deviations lower than the mean, it raises the possibility of microcephaly.

However, it is worth noting that individual variations may occur without organic deviation, and therefore further examinations to exclude false positivity is always important in the diagnosis of microcephaly. Other imaging, MRI, 3D or 4D ultrasound may be helpful. If a genetic abnormality is suspected, depending on the gestational age, amniocentesis and detailed genetic testing should be considered, especially if microcephaly is associated with other suspected signs (e.g. Intrauterine Growth Restriction, IUGR).

### *2.7.5 Postnatal morphology and associated disorders*

Microcephaly may be associated with certain syndromes. One of these is the autosomal recessive Meier-Gorlin syndrome, which is caused by mutations in the *ORC1, ORC4, and ORC6, CDT1* or *CDC6* gene. The syndrome is one of the primordial dwarfisms and is characterised by intrauterine growth retardation, absence of patella, small ears and microcephaly. Pulmonary emphysema is common [51]. Other notable conditions include Nijmegen-Breakage syndrome, Ligase IV syndrome, Warsaw-Breakage syndrome, severe combined immunodeficiency (SCID) or Bloom syndrome [52].

### **2.8 Sacrococcygeal teratoma**

### *2.8.1 Epidemiology*

Sacrococcygeal teratoma is the most common neonatal tumour with a prevalence of 0.027/1000 live births. Its origin is pluripotent cell proliferation with tissue from all three germinal discs. The origin of the cells is remnant cells of the primitive streak or primordial germ cells [53]. It is more common in female foetuses, with a 4:1 ratio [54].

### *2.8.2 Fetal morphology and prognosis*

The typical site of the tumour is the sacral region, hence its name, and it can often grow very large. In terms of pathology, it can be benign (mature) or malignant (immature). The majority of tumours (90%) are benign [55]. The tumour may be cystic or solid, as well as mixed in appearance. Often it may degenerate secondarily, calcify, or may contain haemorrhagic or necrotic regions [55].

The Altman classification was established based on the anatomical location of the tumour. Altman I is largely located externally, II has an associated intrapelvic tumour, III is largely located in the abdominal cavity, and IV is predominantly located presacrally, often without an externally visible tumour [56].

At prenatal diagnosis, the prognosis is poor, with frequent intrauterine death, mainly due to cardiac failure. In contrast, the prognosis is excellent after surgical intervention for postnatally diagnosed sacrococcygeal teratomas [54].

### *2.8.3 Aetiology*

Sacrococcygeal teratoma is rarely associated with chromosomal abnormalities. There is literature evidence that sacrococcygeal teratoma can be associated with partial 13q22 trisomy [57]. Mutations associated with the 12p region are common in adult germ cell tumours, but this mutation has not been detected in "pure" sacrococcygeal teratomas [58]. However, the 12p mutation is common in sacrococcygeal teratomas where a yolk sac component is also present in the tumour. Based on this, Emans et al. suggest that sacrococcygeal teratomas should be classified into two groups depending on the absence or presence of the 12p isochromosome [59].

Rarely, sacrococcygeal teratoma may be part of the Currarino triad. It is an autosomal dominant inherited disorder with mutations in the *HLXB9* gene in the 7q36 region and is associated with anorectal malformations and presacral tissue proliferation and tumours

in addition to teratoma. Presacral tumours associated with the Currarino triad have a much lower chance of malignancy than non-syndromic forms [60].

In other rare cases, it may be associated with 3q trisomy, resulting in a Cornelia de Lange syndrome-like phenotype (short stature, bone developmental malformations, mental retardation, facial developmental abnormalities) [59].

### *2.8.4 Diagnostics*

One of the most important suspicious signs is a larger uterus compared to the gestational age. This is caused by the size of the tumour or by the associated polyhydramnios. The visible tumour mass required to confirm the suspicion may be seen on ultrasound from as early as week 13, but its differential diagnosis is difficult, as the visible mass in the sacral region may also be pseudocyst, obstructive uropathy or meconium. In such cases, as is often the case in neurodevelopmental disorders, it is worthwhile to have an additional MRI scan.

An enlarged placenta and/or fetal hydrops may cause the mother to develop a condition similar to eclampsia, maternal mirror syndrome.

### *2.8.5 Postnatal morphology and associated disorders*

The American Academy of Paediatrics Surgical Section (AAPSS) has developed a classification system that allows inferring the chance of malignancy and future complications depending on the presence of presacral and external tumours, the diagnosis, the success of the resection. In the I to IV scheme, grade I is the mildest with the least tendency to malignancy, while grade IV is the most severe and most likely to malign [55].

Associated abnormalities are usually consequential, so obstruction of the urinary tract, hydronephrosis, rectal atresia, bony malformation of the sacral region as well as fetal hydrops may occur [55]. Hip dysplasia and hydronephrosis may also be associated with sacrococcygeal teratoma in an unconsequential manner, so screening for these is essential both ante- and postnatally [56].

### **2.9 Kinked brainstem**

### *2.9.1 Epidemiology*

Kinked brainstem is an extremely rare condition. It is often only recognised postnatally. Precise figures on its incidence are not yet available.

### *2.9.2 Fetal morphology and prognosis*

A kinked brainstem (twisted brainstem, fractured brainstem, also known as a Z-shaped brainstem) is a rare lesion, a sign of severe neurodysgenesis [61] on pre- or postnatal brain MRI scans. It usually occurs in association with other neurodevelopmental disorders and has a poor prognosis [62].

The posterior fossa is formed early during gestation. Brainstem folding occurs between the third and eighth week, with cerebellum development complete by the 16th week of gestation. Between the third and fifth week, the forebrain folds in accordance with the developing brainstem structures, creating the flexura cephalica, flexura pontis and flexura cervicalis. In the kinked brainstem, the angle of the

flexures is increased, normal brainstem and cerebellar development are inhibited, and cerebellar hypoplasia is, therefore, an associated abnormality in almost all cases [61].

### *2.9.3 Aetiology*

So far, three syndromes have been identified in which kinked brainstem is present as an associated disorder: alpha-dystroglycanopathies (e.g., Walker-Warburg syndrome), tubulinopathies and X-linked hydrocephalus.

Alpha-dystroglycanopathies are heterogeneous congenital muscular dystrophies with brain, muscle and eye involvement [63]. At the more severe end of the spectrum is autosomal recessive Walker-Warburg syndrome, a defect in O-mannosyltransferase. It is often associated with ocular abnormalities (e.g. microphthalmia, retinal detachment), but these can often only be diagnosed after birth. Other alpha-dystroglycanopathies include muscle-eye-brain disease, Fukuyama muscular and cerebral dystrophy and muscle-eye-brain disease with bilateral multicystic leukodystrophy.

Alpha-dystroglycanopathy may be suspected if cobblestone lissencephaly is present. The trunks may be enlarged. Encephalocele is not a diagnostic criterion but may confirm suspicion [61, 62].

The genes identified so far that cause alpha-dystroglycanopathy are *FKRP, FKTN, POMT1, POMT2, POMGnT1, LARGE, ISPD, GTDC2, DAG1, TMEM5, B3GALNT2, B3GNT1, GMPPB, SGK196, DPM1, DPM2, DPM3, DOLK* [64].

There are two types of tubolinopathy, a more severe and a milder form. The more severe form is associated with microlissencephaly and 'kinked brainstem', the milder form is associated with more non-specific nervous system abnormalities. Three genes have been identified so far in its background: *TUBA1A* (chromosome 12), *TUBB2B* (chromosome 6) and *TUBB3* (chromosome 16) [65].

X-linked hydrocephalus is caused by the *L1CAM* (X-chromosome) mutation. It is suspected if the fetus is a boy and the cerebral aqueduct is not detectable on MRI even with a high T2 signal (however, this is difficult to diagnose if the fetus is small or moves around a lot during the scan). Spasticity and adduction of the thumbs may be associated (mainly seen on dynamic ultrasound, but not a diagnostic criterion). Usually, the hemispheres and trunks are not affected by the lesion [62].

### *2.9.4 Diagnostics*

The abnormality is usually diagnosed prenatally during an MRI scan for suspected ventriculomegaly or other intracranial lesions. If the anomaly has not been diagnosed prenatally, a newborn with a kinked brainstem will require intensive care and will be in poor condition. Regardless of the associated abnormalities, the newborn presents with a variety of neurological symptoms, hypotonia and seizures [62].

### *2.9.5 Postnatal morphology and associated disorders*

The kinked brainstem refers to the increase in the angle of the pontomesencephalic transition, exact figures have not been described so far. The brainstem may dislocate posteriorly or anteriorly at the midbrain bridge level. It is often associated with other intracranial abnormalities. Cerebellar hypoplasia is almost always present.

Other associated abnormalities may include ventriculomegaly, dys- or agenesis of the corpus callosum, delayed cortical development, neuron migration

disorders (e.g., lissencephaly), Dandy-Walker malformation, vertex encephalocele, abnormal cerebral hemispheres or abnormal head size (micro- or macrocephaly) [61].

Polymicrogyria and cobblestone lissencephaly are strongly suggestive of alphadystroglycanopathy, but the assessment of neuronal migration is difficult prenatally because the fetal brain is brainstem-rich until about 16 weeks gestation. Cerebellar cysts may also be present, however, these do not develop until the second week after birth [63].

The complicating factor is the secondary damage to cortical structures due to preexisting ventriculomegaly and hydrocephalus.

In a review of seven cases, Stroustrup et al. found that in two cases, the "kinked brainstem" was misidentified as a cerebellum on ultrasound [61]. Since the posterior fossa and the brainstem area are difficult to examine by ultrasound, it is advisable to request an MRI scan in case of a suspicious finding.

Theoretically, the abnormality can be diagnosed from week 7, but in practice, it is usually detected during the second-trimester screening.

### **2.10 Iniencephaly**

### *2.10.1 Epidemiology*

Iniencephaly is a complex malformation characterised by the absence of a neck, pronounced cervicothoracic lordosis and spina bifida.

Its prevalence is very rare and varies between 1 and 0.02/1000 live births, however, the actual prevalence may be higher, as iniencephaly is not always described as part of complex disorders [66].

### *2.10.2 Fetal morphology and prognosis*

It is characterised by the complete or partial absence of the os occipital scales and of the cervical and thoracic vertebrae, an irregular fusion of the existing vertebrae and absence of the neck due to abnormalities in the closure of the vertebral arch. The foramen magnum is wider, while the posterior fossa is usually smaller. Due to the high degree of lordosis of the cervicothoracic spinal segment, the head is strongly tilted backwards, the face is upward (so-called "stargazing") and the trunk is shortened. It is often associated with other neural tube defects, open spina bifida or anencephaly. The disease has a very poor prognosis. If born alive, the newborn dies within a few hours (although one case has been described where the affected individual survived to adulthood and retained his or her intellect) [67].

We distinguish between two types of iniencephaly, iniencephaly apertus (with encephalocele) and iniencephaly clausus (without encephalocele) [68].

### *2.10.3 Aetiology*

Its occurrence is predominantly sporadic. It is more common in female foetuses. Environmental effects have been described in association with maternal syphilis and drug intoxication. Chen et al. found chromosomal abnormalities in 5 of 16 cases studied (two cases of trisomy 18, two cases of trisomy of chromosome 13 mosaic and one case of monosomy of chromosome X mosaic) [66].

Since this is a type of neural tube defect, adequate folate supplementation can reduce the chances of its development, and all the factors described above as leading to the development of neural tube defects also contribute to the development of iniencephaly.

### *2.10.4 Diagnostics*

Cuillier et al. diagnosed iniencephaly by transvaginal ultrasound at the 9th gestational week as the earliest on the basis of acrania, encephalocele and shortened spine [69]. Iniencephaly can be diagnosed with certainty from gestational week 13. Ultrasound signs include extreme dorsiflexion of the head, abnormally short and deformed spine and occipital meningocele. Polyhydramnios is always present.

In terms of differential diagnosis, it should be distinguished from cervical hyperextension, prenatal teratoma, lymphangioma, cervical myelomeningocele, Klipper-Feil and Jarcho-Levin syndromes.

Klipper-Feil syndrome is caused by a failure of segmentation of the cervical vertebrae early in gestation. There is no spina bifida in this case. There are usually associated neurological symptoms, often associated with deafness. Most cases are sporadic, but autosomal dominant and recessive forms have been described [66]. Klipper-Feil syndrome can be subsequently treated surgically [68].

### *2.10.5 Postnatal morphology and associated disorders*

In 84% of cases, other anomalies are also associated: anencephaly, encephalocele, hydrocephalus, cyclopia, mandibular defect, cleft lip and palate, cardiovascular anomalies, diaphragmatic hernia, omphalocele, gastroschisis, situs inversus, ren polycysticum, arthrogriposis. It may also be associated with an undescribed frequency of Dandy-Walker malformation, hydronephrosis, atresia of the gastrointestinal system and umbilical artery singularis [66].

### **2.11 The epigenetics of fetal craniospinal malformations**

As the cause of craniospinal malformations is usually multifactorial, it is understandable that epigenetic pathways should play an important role in neurulation, although it is yet a poorly researched area. The relation between neural tube defects and epigenetic pathways is the most studied part.

Multiple ways have been identified which affect the formation of neural tubes epigenetically. The most reviewed topic is DNA methylation, although only animal studies are available. In DNA methyltransferases *DNMT3A* and *DNMT3B* knockedout mice neural tube defects are more common. It is also possible that *DNMT3L* plays a role in the process too, although it is less researched [70]. Mouse models have also been made to examine histone acetyltransferases, and it has been identified that histone acetyltransferases *GCN5* and *CBP* are both play a significant role in neurulation. It is supposed that it has an impact on human neural tube development too. Nucleosome positioning, another example of epigenetic regulation, is also studied in association with NTDs, as a subtype of ATP-dependent chromatin remodelling complex, the SWI/SNF-related nucleosome remodelling BAF complex has been proved to play an important role in the relation of neural tube closing in mice. Also, micro RNAs, like CECR2 have been proven to cause exencephaly in animal models [71].

It is clear that the epigenetic pathways do not function on their own, but rather as a part of a complex system. It would be important to examine and understand more about that as a part of future research.

### **3. Conclusion**

In summary, by the second trimester, developmental disorders affecting the nervous system can be diagnosed with a high degree of certainty by ultrasound, but in case of doubtful findings, additional imaging tests should be performed. The development of these disorders is multifactorial; both environmental and genetic factors play a role. In the case of an abnormal ultrasound finding, genetic testing should be performed to confirm the finding and to rule out inherited mutations in subsequent pregnancies.

### **Author details**

Artur Beke\*, Virág Bartek and Aténé Simonyi Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary

\*Address all correspondence to: beke.artur@med.semmelweis-univ.hu

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

### **References**

[1] Chen Z, Kuang L, Finnell RH, Wang H. Genetic and functional analysis of SHROOM1-4 in a Chinese neural tube defect cohort. Human Genetics. 2018;**137**(3):195-202

[2] Colas J-F, Schoenwolf GC. Towards a cellular and molecular understanding of neurulation. Developmental Dynamics. 2001;**221**(2):117-145. DOI: 10.1002/ dvdy.1144

[3] Seidahmed MZ, Abdelbasit OB, Shaheed MM, Alhussein KA, Miqdad AM, Khalil MI, et al. Epidemiology of neural tube defects. Saudi Medical Journal. 2014;**35**(Suppl 1):S29-S35

[4] Tafuri SM, Lui F. Embryology, Anencephaly. 2021 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Jan 2022. PMID: 31424828

[5] Papp Z. A szülészet-nőgyógyászat tankönyve. Vol. 4. Budapest, Semmelweis Kiadó; 2009

[6] Horcajadas A, Palma A, Khalon BM. Frontoethmoidal encephalocele. Report of a case. Neurocirugía (Asturias, Spain). 2019;**30**(2):94-99. DOI: 10.1016/j. neucir.2018.02.006

[7] Suwanwela C, Suwanwela N. A morphological classification of sincipital encephalomeningoceles. Journal of Neurosurgery. Feb 1972;**36**(2):201-211. DOI: 10.3171/jns.1972.36.2.0201. PMID: 5008734

[8] Kancherla V, Wagh K, Johnson Q, Oakley GP Jr. A 2017 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Research. 2018;**110**(14):1139-1147. DOI: 10.1002/ bdr1132.1366

[9] Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. American Journal of Human Genetics. 1999;**64**(4):1045-1055

[10] McGreevy EM, Vijayraghavan D, Davidson LA, Hildebrand JD. Shroom3 functions downstream of planar cell polarity to regulate myosin II distribution and cellular organization during neural tube closure. Biology Open. 2015;**4**(2):186-196

[11] Murdoch JN, Damrau C, Paudyal A, Bogani D, Wells S, Greene NDE, et al. Genetic interactions between planar cell polarity genes cause diverse neural tube defects in mice. Disease Models & Mechanisms. 2014;**7**(10):1153-1163

[12] Valentin M, Coste Mazeau P, Zerah M, Ceccaldi PF, Benachi A, Luton D. Acid folic and pregnancy: A mandatory supplementation. Annales d'Endocrinologie. 2018;**79**(2):91-94

[13] Avagliano L, Massa V, George TM, Qureshy S, Bulfamante GP, Finnell RH. Overview on neural tube defects: From development to physical characteristics. Birth Defects Research. 2019;**111**(19):1455-1467. DOI: 10.1002/ bdr1452.1380

[14] Turhan AH, Isik S. Neural tube defects: A retrospective study of 69 cases. Asian Journal of Neurosurgery. 2019;**14**(2):506-509

[15] Micu R, Chicea AL, Bratu DG, Nita P, Nemeti G, Chicea R. Ultrasound and magnetic resonance imaging in

the prenatal diagnosis of open spina bifida. Medical Ultrasonography. 2018;**20**(2):2018. DOI: 10.11152/ mu-1325

[16] Kennedy D, Chitayat D, Winsor EJT, Silver M, Toi A. Prenatally diagnosed neural tube defects: Ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. American Journal of Medical Genetics. 1998;**77**(4):317-321

[17] Wainwright HC. Embryo and Fetal pathology. Color atlas with ultrasound correlation. Journal of Clinical Pathology. 2005;**58**:784. DOI: 10.1136/ jcp.2005.026047

[18] D'Antonio F, Zafeiriou DI. Fetal ventriculomegaly: What we have and what is still missing. European Journal of Pediatric Neurology. 2018;**22**(6):898-899. DOI: 10.1016/j.ejpn.2018.11.005

[19] Tully HM, Dobyns WB. Infantile hydrocephalus: A review of epidemiology, classification and causes. Europen Journal of Medical Genetics. 2014;**57**(8):359-368. DOI: 10.1016/j. ejmg.2014.06.002

[20] Saugier-Veber P, Marguet F, Lecoquierre F, Adle-Biassette H, Guimiot F, Cipriani S, et al. Hydrocephalus due to multiple ependymal malformations is caused by mutations in the MPDZ gene. Acta Neuropathologica Communications. 2017;**5**(1):36. DOI: 10.1186/ s40478-017-0438-4

[21] Yamasaki M, Nonaka M, Bamba Y, Teramoto C, Ban C, Pooh RK. Diagnosis, treatment, and long-term outcomes of fetal hydrocephalus. Seminars in Fetal and Neonatal Medicine. 2012;**17**(6):330- 335. DOI: 10.1016/j.siny.2012.07.004

[22] Fox NS, Monteagudo A, Kuller JA, Craigo S, Norton ME. Mild fetal

ventriculomegaly: Diagnosis, evaluation, and management. American Journal of Obstetrics and Gynecology. 2018;**219**(1):B2-B9. DOI: 10.1016/j. ajog.2018.04.039

[23] Shaheen R, Sebai MA, Patel N, Ewida N, Kurdi W, Altweijri I, et al. The genetic landscape of familial congenital hydrocephalus. Annals of Neurology. 2017;**81**(6):890-897. DOI: 10.1002/ ana.24964

[24] Assémat E, Crost E, Ponserre M, Wijnholds J, Le Bivic A, Massey-Harroche D. The multi-PDZ domain protein-1 (MUPP-1) expression regulates cellular levels of the PALS-1/PATJ polarity complex. Experimental Cell Research. 2013;**319**(17):2514-2525. DOI: 10.1016/j.yexcr.2013.07.011

[25] Drielsma A, Jalas C, Simonis N, Désir J, Simanovsky N, Pirson I, et al. Two novel CCDC88C mutations confirm the role of DAPLE in autosomal recessive congenital hydrocephalus. Journal of Medical Genetics. 2012;**49**(11):708-712. DOI: 10.1136/jmedgenet-2012-101190

[26] Ishida-Takagishi M, Enomoto A, Asai N, Ushida K, Watanabe T, Hashimoto T, et al. The dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility. Nature Communications. 2012;**3**:859. DOI: 10.1038/ncomms1861

[27] Blaas HG, Eik-Nes SH. Sonoembryology and early prenatal diagnosis of neural anomalies. Prenatal Diagnosis. 2009;**29**(4):312-325. DOI: 10.1002/pd.2170

[28] Breeze A, Alexander P, Murdoch E, Missfelder-Lobos H, Hackett G, Lees C. Obstetric and neonatal outcome in severe ventriculomegaly. Prenatal Diagnosis. 2007;**27**:124-129. DOI: 10.1002/pd.1624

*Fetal Craniospinal Malformations: Aetiology and Diagnosis DOI: http://dx.doi.org/10.5772/intechopen.103691*

[29] Pisapia JM, Sinha S, Zarnow DM, Johnson MP, Heuer GG. Fetal ventriculomegaly: Diagnosis, treatment, and future directions. Child's Nervous System. 2017;**33**(7):1113-1123. DOI: 10.1007/s00381-017-3441-y

[30] Kahle KT, Kulkarni AV, Limbrick DD Jr, Warf BC. Hydrocephalus in children. Lancet. 2016;**387**(10020):788-799. DOI: 10.1016/s0140-6736(15)60694-8

[31] Swaiman KF. Swaiman's pediatric neurology: Principles and practice. 6th edition. Edinburgh: Elsevier Saunders; 2012;S199-202

[32] Hunter A, Jimenez C, Tawagi F. Familial renal-hepatic-pancreatic dysplasia and Dandy-Walker cyst: A distinct syndrome? American Journal of Medical Genetics. 1991;**41**(2):201-207

[33] Capra V, Iacomino M, Accogli A, Pavanello M, Zara F, Cama A, et al. Chiari malformation type I: What information from the genetics? Child's Nervous System. 2019;**35**(10):1665-1671. DOI: 10.1007/s00381-019-04322-w

[34] Lieb JM, Ahlhelm FJ. Balkenfehlbildungen. Der Radiologe. 2018;**58**(7):636-645. DOI: 10.1007/ s00117-018-0388-2

[35] Palmer EE, Mowat D. Agenesis of the corpus callosum: A clinical approach to diagnosis. American Journal of Medical Genetics. 2014;**166c**(2):184-197. DOI: 10.1002/ajmg.c.31405

[36] Aicardi J. Aicardi syndrome. Brain and Development. 2005;**27**(3):164-171. DOI: 10.1016/j.braindev.2003.11.011

[37] Santo S, D'Antonio F, Homfray T, Rich P, Pilu G, Bhide A, et al. Counseling in fetal medicine: Agenesis of the corpus callosum. Ultrasound in Obstetrics and Gynecology. 2012;**40**(5):513-521. DOI: 10.1002/uog.12315

[38] Ming JE, Muenke M. Multiple hits during early embryonic development: Digenic diseases and holoprosencephaly. American Journal of Human Genetics. 2002;**71**(5):1017-1032. DOI: 10.1086/344412

[39] Tekendo-Ngongang C, Muenke M, Kruszka P. Holoprosencephaly overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews(®). Seattle: University of Washington; 1993

[40] Ming JE, Roessler E, Muenke M. Human developmental disorders and the sonic hedgehog pathway. Molecular Medicine Today. 1998;**4**(8):343-349. DOI: 10.1016/s1357-4310(98)01299-4

[41] Cohen MM Jr. Holoprosencephaly: Clinical, anatomic, and molecular dimensions. Birth Defects Research. 2006;**76**(9):658-673. DOI: 10.1002/ bdra.20295

[42] Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, et al. Identification of sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nature Genetics. 1996;**14**(3):353-356. DOI: 10.1038/ ng1196-353

[43] Geng X, Speirs C, Lagutin O, Inbal A, Liu W, Solnica-Krezel L, et al. Haploinsufficiency of Six3 fails to activate sonic hedgehog expression in the ventral forebrain and causes holoprosencephaly. Developmental Cell. 2008;**15**(2):236-247. DOI: 10.1016/j. devcel.2008.07.003

[44] Kousa YA, du Plessis AJ, Vezina G. Prenatal diagnosis of holoprosencephaly. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2018;**178**(2):206-213. DOI: 10.1002/ ajmg.c.31618

[45] Kaliaperumal C, Ndoro S, Mandiwanza T, Reidy F, McAuliffe F, Caird J, et al. Holoprosencephaly: Antenatal and postnatal diagnosis and outcome. Childs Nervous System. 2016;**32**(5):801- 809. DOI: 10.1007/s00381-016-3015-4

[46] Arroyo HA. Microcephaly. Medicina (B Aires). 2018;**78**(Suppl 2):94-100 (Microcefalia.)

[47] Woods CG, Parker A. Investigating microcephaly. Archives of Disease in Childhood. 2013;**98**(9):707-713. DOI: 10.1136/archdischild-2012-302882

[48] Faheem M, Naseer MI, Rasool M, Chaudhary AG, Kumosani TA, Ilyas AM, et al. Molecular genetics of human primary microcephaly: An overview. BMC Medical Genomics. 2015;**8**(Suppl 1(Suppl 1)):S4. DOI: 10.1186/1755-8794-8-s1-s4

[49] de Oliveira WK, de França GVA, Carmo EH, Duncan BB, de Souza Kuchenbecker R, Schmidt MI. Infectionrelated microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: A surveillance-based analysis. Lancet. 2017;**390**(10097):861-870. DOI: 10.1016/ s0140-6736(17)31368-5

[50] de Castro M, Doin Trigo LA, Benini-Junior JR, Brito LGO, Marba STM, Amaral E. Ultrasound diagnosis of microcephaly: A comparison of three reference curves and postnatal diagnosis. Archives of Gynecology and Obstetrics. 2019;**300**(5):1211-1219. DOI: 10.1007/s00404-019-05234-5

[51] Bicknell LS, Walker S, Klingseisen A, Stiff T, Leitch A, Kerzendorfer C, et al. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nature Genetics. 2011;**43**(4):350-355. DOI: 10.1038/ng.776

[52] Alcantara D, O'Driscoll M. Congenital microcephaly. American Journal of Medical Genetics. 2014; **166c**(2):124-139. DOI: 10.1002/ ajmg.c.31397

[53] Sadler TW, Langman J. Langman's Medical Embryology. Vol. 1. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012. p. c2012

[54] Taguchi T. Sacrococcygeal teratoma: Nationwide survey and guidelines. Pediatrics International. 2019;**61**(7):633. DOI: 10.1111/ped.13933

[55] Graf JL, Albanese CT. Fetal sacrococcygeal teratoma. World Journal of Surgery. 2003;**27**(1):84-86. DOI: 10.1007/s00268-002-6741-6

[56] Kremer MEB, Althof JF, Derikx JPM, van Baren R, Heij HA, Wijnen M, et al. The incidence of associated abnormalities in patients with sacrococcygeal teratoma. Journal of Pediatric Surgery. 2018;**53**(10):1918-1922. DOI: 10.1016/j.jpedsurg.2018.01.013

[57] Dalal SS, Berry T, Pimentel VM. Prenatal Sacrococcygeal Teratoma diagnosed in a Fetus with partial trisomy 13q22. Case Report in Obstetrics and Gynecology. 2019;**2019**:2892869. DOI: 10.1155/2019/2892869

[58] Mylonas KS, Kao CS, Levy D, Lordello L, Dal Cin P, Masiakos PT, et al. Clinicopathologic features and chromosome 12p status of Pediatric Sacrococcygeal Teratomas: A multiinstitutional analysis. Pediatric and Development Pathology. 2019;**22**(3):214- 220. DOI: 10.1177/1093526618798771

[59] Emerson RE, Kao CS, Eble JN, Grignon DJ, Wang M, Zhang S, et al. Evidence of a dual histogenetic pathway of sacrococcygeal teratomas. Histopathology. 2017;**70**(2):290-300. DOI: 10.1111/his.13062

*Fetal Craniospinal Malformations: Aetiology and Diagnosis DOI: http://dx.doi.org/10.5772/intechopen.103691*

[60] Emans PJ, Kootstra G, Marcelis CL, Beuls EA, van Heurn LW. The Currarino triad: The variable expression. Journal of Pediatric Surgery. 2005;**40**(8):1238-1242. DOI: 10.1016/j.jpedsurg.2005.05.004

[61] Stroustrup Smith A, Levine D, Barnes PD, Robertson RL. Magnetic resonance imaging of the kinked fetal brain stem: A sign of severe dysgenesis. Journal of Ultrasound in Medicine. 2005;**24**(12):1697-1709. DOI: 10.7863/ jum.2005.24.12.1697

[62] Stanislavsky A, Kang O. Kinked brainstem. Reference article, Radiopaedia.org. [Accessed on 25 Mar 2022] DOI: 10.53347/rID-51058

[63] Amir T, Poretti A, Boltshauser E, Huisman TA. Differential diagnosis of ventriculomegaly and brainstem kinking on fetal MRI. Brain Development. 2016;**38**(1):103-108. DOI: 10.1016/j. braindev.2015.05.006

[64] Bönnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscular Disorders. 2014;**24**(4):289-311. DOI: 10.1016/j. nmd.2013.12.011

[65] Cabet S, Karl K, Garel C, Delius M, Hartung J, Lesca G, et al. Two different prenatal imaging cerebral patterns of tubulinopathy. Ultrasound in Obstetrics & Gynecology. 2021;**57**(3):493-497. DOI: 10.1002/uog.22010

[66] Chen CP. Prenatal diagnosis of iniencephaly. Taiwanese Journal of Obstetrics and Gynecology. 2007;**46**(3):199-208. DOI: 10.1016/ s1028-4559(08)60021-2

[67] Holmes LB, Toufaily MH, Westgate MN. Iniencephaly. Birth Defects Research. 2018;**110**(2):128-133. DOI: 10.1002/bdr2.1082

[68] Tanriverdi EC, Delibas IB, Kamalak Z, Kadioglu BG, Bender RA. A Fetus with Iniencephaly delivered at the third trimester. Case Report in Medicine. 2015;**2015**:520715. DOI: 10.1155/2015/520715

[69] Cuillier F, Koenig P, Lagarde L, Cartault JF. Transvaginal sonographic diagnosis of iniencephaly apertus and craniorachischisis at 9 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 2003;**22**(6):657-658. DOI: 10.1002/uog.895

[70] Greene ND, Stanier P, Moore GE. The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics. 2011;**6**(7):875-883. DOI: 10.4161/epi.6.7.16400

[71] Wilde JJ, Petersen JR, Niswander L. Genetic, epigenetic, and environmental contributions to neural tube closure. Annual Reviews of Genetics. 2014;**48**:583-611. DOI: 10.1146/ annurev-genet-120213-092208

### **Chapter 8**

## Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania

*Hadi Rahimian, Ramona Ana Maria Rahimian and Radu Vladareanu*

### **Abstract**

Spina bifida and myelomeningocele, although frequent, present difficulties when it comes to diagnosis and clinical management. The recent developments in ultrasound and MRI technologies and software, allow for an easier and more precise diagnosis. As such, in the first part of our chapter we will present general information, such as etiology, pathophysiology and methods of diagnosis. Fetal surgery, open or fetoscopic, represents a cure in most cases of spina bifida and in other cases reduces the chances of major developmental issues in babies born with this affliction. In the second part of our chapter, we will present the surgical protocols for both procedures, the indications, and the statistics that we have acquired in the cases we have diagnosed and operated on in the Regina Maria Maternity Hospital, Bucharest, the only center in Romania where these procedures are available.

**Keywords:** Spina bifida, Myelomeningocele, Open fetal surgery, Fetoscopic surgery, Fetal prognosis

### **1. Introduction**

Spinal cord defects appear because of failure in the closure of the neural folds. These defects usually appear during the third and fourth weeks of gestation. Neural tube defects (NTD) can affect the meninges, vertebrae, muscles, and the skin. ([1]— Langman's). Meningocele and myelomeningocele are the most frequently encountered spinal dysraphisms.

Closed spinal defects include spina bifida occulta, lipomyelomeingocele and a multitude of other conditions.

Open spinal dysraphisms are mostly compatible with survival but usually the quality of life of the patient will be affected, depending on the level of the aperture. Symptoms are comprised of inability to walk, incontinence, scoliosis, digestive disorders, and hydrocephalus [1, 2].

### **2. Embryology**

Spinal dysraphisms appear from a failure of either: gastrulation, primary neurulation, disjunction or secondary neurulation.

Gastrulation is the process where the bilaminar embryonic disc becomes trilaminar. When this process happens, the neuroenteric canal forms and creates a temporary connection between the dorsal and ventral surface of the trilamiar disc. It is thought that split cord malformations and neuroenteric cysts arise from the persistence of this canal.

Neurulation begins when the formation of the central nervous system by signaling the ectoderm to differentiate and form the neural plate. This plate folds inwards, it's edges connecting to one another, completing the process known as primary neurulation.

After the primary neurulation, the neural tube separates form the ectodermic tissue, this process is known as disjunction. During this process, the mesoderm moves between the ectoderm and the neural tube, creating the meninges, skull, vertebrae and the paraspinal muscles. If this process starts prematurely or it is incomplete, a lypomeningocele or a dermal sinus may form [1].

The secondary neurulation is the formation of the spinal cord above the midsacrum.

Open spinal defects appear from the delay or cessation of the primary neurulation.

Defects during the second neurulation are believed to be the cause for closed spinal dysraphisms.

Signaling pathways and cellular functions are also included in the formation of neural tube defects; planar cell polarity signaling, sonic hedgehog signaling, retinoid signaling and many others are though to be factors.

Some genetic factors, as well as environment factors are also included as rick factors of developing spinal dysraphisms, such as: valproic acid, fungal products (fumonisin), carbamazepine, trimethoprim, and folate and vitamin B12 deficiency, inositol, and maternal diabetes mellitus (environmental factors), the genetic factors include C67TT and a1298C polymorphisms of the methylenetetrahydrofolate reductase, this results in a 1.8-fold increase in risk of NTDs [2, 3].

### **3. Clinical diagnosis**

All pregnancies are at risk for neural tube defects, as such all women of fertile age as well as all pregnant women are encouraged to take folic acid supplements. It is paramount to take a full maternal history, as women with a history of anticonvulsant medication, diabetes or obesity are at higher risk for neural tube defects.

Prenatal clinical diagnosis relies on maternal elevated alpha-fetoprotein levels and amniocentesis, usually performed after 15–16 weeks of gestation. Although an early amniocentesis can be performed between 10 and 14 weeks of gestation, the low quantity amniotic fluid at this gestational age forces the practitioner to withdraw a smaller quantity which may not provide enough cells for analysis.

In the case of neural tube defects, an elevated alpha-fetoprotein and acetylcholinesterase level in the amniotic fluid and maternal blood usually prompts further investigations, such as high-resolution fetal ultrasonography and MRI [3, 4].

*Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania DOI: http://dx.doi.org/10.5772/intechopen.99922*

### **4. Imaging**

### **4.1 Ultrasound**

Identifying spinal anomalies during a routine ultrasound screening usually varies depending on the skill and expertise of the operator.

A very detailed protocol should be followed for a correct diagnosis, both axial and longitudinal views of the spine have to be obtained. It is important to know the precise timing of ossification for each segment of spine. At 16 weeks ossification is complete up to L5, by 19 weeks it reaches S1 and by 22 weeks the process is complete. The best plane for the visualization of everted pedicles is the transverse one, as for an overlying sac, both transverse and longitudinal planes should be used as well as a high frequency transducer that would show cord tethering or placode content (**Figures 1** and **2**).

Chiari II malformations are very often encountered in fetuses with neural tube defects so, it is paramount that the fetal brain is scanned initially. Findings such as a small cisterna magna along with a rounded cerebellum (banana sign), concaved frontal bones (lemon sign) and ventriculomegaly are suggestive for Chiari II malformation. The banana sign has a 99% sensitivity in the diagnostic, the lemon sign has a lower sensitivity rate and can be present in normal fetuses [5].

### **4.2 MRI**

The MRI has become an invaluable addition in the diagnosis and preoperative preparation of spinal dysraphisms. 1.5 Tesla magnets are usually used although a 3 Tesla magnet can be useful in maximizing image quality. Orthogonal planes can also be used, adjusted to the preceding image set if the fetal position changes (**Figure 3**).

### **Figure 2.**

*Ultrasound picture (same case as* **Figure 1***) in a different position where it is shown that there is no cord tethering (arrow).*

**Figure 3.** *MRI imaging of large, closed spina bifida defect (arrow).*

*Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania DOI: http://dx.doi.org/10.5772/intechopen.99922*

**Figure 4.** *MRI imaging showing closed neural tube defect (arrow).*

### **Figure 5.**

*1. Placement of fetoscopic trocars 2. Uterine wall 3. One hand is holding the fetus in order to create the pocket of gas in front of the operating field.*

In order to pinpoint the fetal position a localizer sequence has to be used to guide the initial imaging plane which is aligned with the fetal anatomy that has to be examined. Ultrafast sequencing can also be used to minimize image degradation by fetal movements (**Figure 3**).

Single shot fast spin echo or half-Fourier acquisition single-shot fast spin echo sequences at 2 to 4 mm slice thickness are used to provide most of the diagnostic information (**Figure 4**) [6].

### **5. Treatment**

### **5.1 Fetal surgery**

### *5.1.1 History of spina bifida surgeries*

The first time a spina bifida repair was performed was in 1994 using an endoscopic technique. In 1997 the first open(hysterotomy) in-utero spina bifida repair was performed at Vanderbilt University and at The Children's Hospital of Philadelphia.

The experience of these institutions suggested that babies treated in utero had a decreased incidence of hindbrain herniation and that after three weeks post-intervention, the hindbrain structures would ascent. Chiari II malformations were improved whereas other Chiari modifications were not (such as thinning of the corpus callosum), however it was shortly proven that the placement of fetal shunts is unnecessary in most cases.

The follow up also showed that after fetal surgery was performed the number of patients needing shut placement after birth has decreased significantly. Although most infants did not require shunting in the newborn period, some required it within the first year of life. A comparison between patients that underwent the fetal procedure prior to 26 weeks of gestation and those after 25 weeks of gestation showed that early fetal closure eliminates the leakage of spinal fluid and creates a back-pressure, reducing the herniation of the hindbrain.

Because of the selection and short follow-up processes in these cases, it was difficult to demonstrate the benefit to lower extremity function and sphincter continence, as well as cognitive function. However, findings showed an improved healing and scar formation, resulting in a more esthetic result [7, 8].

### *5.1.2 Surgical technique*

The decision to perform fetal surgery for spina bifida relies on the inclusion and exclusion criteria established in the world renown MOMS study (**Table 1**). To make a correct and informed decision, a high-resolution fetal ultrasonography, a fetal MRI scan as well as maternal and fetal serology are necessary in order to assess the extent of the defect. In any fetal operation maternal safety comes first, after which the next major goal is avoiding preterm labor. Spinal dysraphism repairs should be performed between 18 and 27 weeks of gestation, prior to this interval the fetal size would be too small and the tissues too fragile to accommodate the intervention and after 27 weeks of gestation there would be no shown benefit to the surgery compared to post-natal repair (**Table 1**).

This surgery requires a team that includes maternal-fetal specialists, neurosurgeons, pediatric surgeons, neonatologists, radiologists, anesthesiologists, and

*Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania DOI: http://dx.doi.org/10.5772/intechopen.99922*


### **Table 1.**

*Inclusion and exclusion criteria according to MOMS (Management of Myelomeningocele study) [7].*

geneticists. The mother should always receive counseling and all the team members should explain their roles in detail before the procedure [7].

Drug therapy to decrease the chances of preterm labor should be administered as follows: magnesium sulfate preoperatively and for the first 18–48 hours following surgery, indomethacin preoperatively and continued for 48 hours, oral nifedipine preoperatively and continued until delivery and terbutaline sulfate administered subcutaneously continuously by a pump if the other medication fails.

Anesthesia in neural dysraphism repairs is particularly complex as it affects both mother and fetus and it must take in consideration the uteroplacental factor. An epidural catheter is placed for postoperative analgesia before the rapid sequence induction and the intubation are performed. Desflurane is usually used for maintaining the anesthesia, but nitrous oxide can also be a choice. Tice the amount of alveolar concentration is usually used to achieve uterine relaxation. In order to keep the arterial blood pressure close to the pre-induction base-line, ephedrine or phenylephrine is used. Vecuronium is administered for neuromuscular blockade.

The fetus also must be anesthetized before incision, usually with a narcotic and a muscle blocker delivered intramuscularly [9].

There are three possible methods of performing spina bifida fetal interventions: open surgery, fetoscopy procedure and endoscopically (abandoned as it presented a high risk of membrane rupture and was proved unsatisfactory compared to the other two methods).

For open surgery, the uterus is exposed though a low transverse abdominal incision, using ultrasonography the fetal and placental positions are determined and the uterus is placed to have proper exposure. Hemostatic sutures are applied where the future incision will be, then with a monopolar cautery the hysterotomy is performed between these sutures. The incision is enlarged using a stapler that simultaneously cuts the uterine wall as well as applies hemostatic absorbable clips that will hold the amniotic membranes (**Figures 6** and **7**). Because the incision is in the upper portion of the uterine segment, it is important to relate to the mother that this and any future pregnancies will have to be delivered by C-section.

Maintaining uterine volume is paramount as it prevents placental separation, contractions, and fetal expulsion. For this reason, warm Ringer lactate solution is continuously pumped into the uterine cavity and the fetus is not completely removed from the cavity, only being moved as much as needed to get optimal access to the operating area (**Figure 8**).

The myelomeningocele is closed rapidly and with as little blood loss as possible, the technique being similar to the standard post-natal variant. The full-thickness skin is incised circumferentially with a 15-blade knife until it reaches the fascia, the sac is mobilized to the facial defect, it is excised from the placode, removing all epithelial tissue

### **Figure 6.**

*Microscopic view of open spina bifida surgery. The amniotic membranes are sutured to the uterine wall. The defect is visible (arow) and our neurosurgeon started the repair.*

### **Figure 7.**

*Open spina bifida surgery. The Folley catheter is used to insert warm saline solution in the uterine cavity to replenish the lost amniotic fluid.*

### *Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania DOI: http://dx.doi.org/10.5772/intechopen.99922*

in order to prevent future epidermoid inclusion cyst formation. The re-neurulation of the placode is not attempted as at this gestational age the tissues are extremely friable. It is preferred that the closure be done with dura and undermined fascia but either dura or fascia alone can lead to a successful result (**Figure 9**). The skin is closed with a 4–0 absorbable PDA suture, if the defect is too large acellular human graft material can be used.

The uterus is closed with a tight two-layer closure and transparent dressing must be used in order to perform future ultrasonographic examinations [7].

The fetoscopic procedure begins as well with a transverse abdominal incision but this time the uterus is taken out of the abdominal cavity. Two or three ports are inserted in the uterine cavity through small incisions, under ultrasonographic guidance (**Figure 5**). A small quantity of amniotic fluid is taken out and replaced with CO2 to have a better visualization. It is very important that before the repair is commenced that a narcotic injection is administered to the fetus in order to have

### **Figure 8.**

*Open spina bifida surgery. Final aspect of the repaired site (arrow).*

**Figure 9.** *Open spina bifida surgery. 1 month post-natal aspect of the surgery site.*

**Figure 10.** *Fetoscopic view of myelomeningocele defect before repair.*

analgesia. The myelomeningocele sac is reduced by the neurosurgeon and the defect is then sutured. In the case of fetoscopic surgery, grafting is not possible as the trocar size does not permit it's passing so the extent of the defect must be meticulously asserted before the procedure (**Figure 10**).

Recent studies have shown that the fetoscopic procedure leads to equal success rates and better post-operative results when it comes to scarring compared to the open surgery. Also, future pregnancies can be delivered vaginally as the uterine scarring is minimal. Fetal short term neurosurgical results are similar to the open fetal surgery, 70% hindbrain herniation ascent and 45% of the patients did not need future treatment for hydrocephaly. The fetoscopic approach minimizes the risk of membrane ruptures and preterm delivery.

### **5.2 Statistics in our materno-fetal surgical center**

In our materno-fetal center Regina Maria Maternity Hospital Baneasa we had a total of 37 patients whose fetuses were diagnosed with spina bifida between 2011 and 2021. Out of these 8 did not have the necessary inclusion criteria and 4 refused the intervention.

At the beginnings we started performing exclusively open surgeries. In total we have performed 18 open surgeries for spina bifida defects, out of these 6 gave birth before 30 weeks of gestation, 5 after 30 weeks of gestation and 7 after 34 weeks of gestation.

As the technology evolved and we have become more proficient in solving these cases, we have decided to perform fetoscopic interventions for spina bifida aswell. As such, from 2011 until 2021 we have performed 8 fetoscopic surgeries. In these cases, 1 patient gave birth before 30 weeks of gestation, 2 after 30 weeks of gestation and 5 after 35 weeks of gestation.

We did not have to perform any emergency hysterectomies during or after the spina bifida defect intervention, but we did have 2 cases that had membrane decollation. The decollation was minor (under 1 cm) in both cases so no treatment was needed.

At the one-year follow-up, we have observed that 6 of the babies had motor function impairment and 3 presented with urinary incontinence. Only 6 out of the 26 patients needed surgery for ventriculomegaly performed after birth.

*Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania DOI: http://dx.doi.org/10.5772/intechopen.99922*

According to our statistics we had a better outcome using the fetoscopic surgical method for spina bifida as the cases of birth under 30 weeks of gestation were significantly lower compared to open surgery. The results for after 30 weeks of gestation and after 34 weeks of gestation are comparable between the open and the fetosopic spina bifida repairment methods (**Table 2**).

Compared to the 2019 Zurich Center for Fetal Diagnosis and Therapy and the MOMS trial, our center delivers comparable results as seen in **Tables 3** and **4**. Even though the number of patients is not an exact match to the MOMS trial, it is comparable to the Zurich study (**Table 3**) [10].

Our values show a diminished rate of maternal complications compared to the MOMS trial, the only prenatal complication encountered was chorioamniotic membrane separation. The hysterotomy site at delivery was intact in 77% of the cases, 20% very thin, 0% had an area of dehiscence and 3% complete dehiscence. Compared to the Zurich study, we showed a higher rate of well-healed hysterotomy site (77% vs. 40%) but a higher rate of complete dehiscence (3% vs. 0%) (**Table 4**).

Our fetal and neonatal outcomes show that compared to the Zurich trial the percentage of apnea and foot deformity is much higher, however when compared to the MOMS trial we show a much lower rate for these complications.


### **Table 2.**

*Percentages of births according to weeks of gestation and surgical method.*


### **Table 3.**

*Infant outcome at 12 months (table modified from Zurich Center data).*

### *Ectopic Pregnancy and Prenatal Diagnosis*


**Table 4.**

*Maternal outcome and fetal or neonatal outcome (table modified from Zurich data Center).*

### **6. Conclusions**

Spina bifida is a spinal dysraphism that has a higher incidence compared to other fetal malformations. Fetal surgery for this defect can restore some if not all the sequelae from hindbrain herniation to incontinence giving back the quality of life to the fetus, thus performing the intervention when the criteria are met is necessary especially since the statistic results are positive.

*Open Fetal Surgery and Fetoscopic Repair in Spina Bifida and Myelomeningocele in Romania DOI: http://dx.doi.org/10.5772/intechopen.99922*

### **Author details**

Hadi Rahimian1 , Ramona Ana Maria Rahimian2 and Radu Vladareanu3 \*

1 Regina Maria Maternity Hospital, Bucharest, Romania

2 Emergency University Hospital Elias, Bucharest, Romania

3 Carol Davila University of Medicine and Pharmacy, Emergency University Hospital Elias, Bucharest, Romania

\*Address all correspondence to: vladareanu@gmail.com

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

### **References**

[1] Langman's Medical Embryology – 12th edition / T.W. Sadler, ISBN 978-1-4511-1342-6

[2] Fanaroff and Martin's Neonatal-Perinatal Medicine, 2-Volume Set, 11th Edition, ISBN 9780323567114:

[3] McComb JG. A practical clinical classification of spinal neural tube defects. Childs Nerv Syst. 2015;31(10):1641-1657

[4] Klaus and Fanaroff's Care of the High-Risk Neonate, 7th edition, ISBN 978-0-323-60854-1: 409-436

[5] Callen's Ultrasonography in Obstetrics and Gynecology 6th Edition, 2016, ISBN 9780323328340:

[6] Obstetric Imaging: Fetal Diagnosis and Care 2nd Edition, 2017, ISBN 9780323445481: 213-226

[7] Fetal Therapy, Cambridge University Press, 2020, ISBN 9781108564434

[8] Moldenhauer JS, Soni S, Rintoul NE, Spinner SS, Khalek N, Martinez-Poyer J, et al. Fetal myelomeningocele repair: the post-MOMS experience at the Children's Hospital of Philadelphia. Fetal Diagn Ther. 2015; 37(3): 235-240.

[9] Ochsenbein-Kölble N, Krähenmann F, Hüsler M, Meuli M, Moehrlen U, MazzoneL, et al. Tocolysis for in utero surgery: atosiban performs distinctly better than magnesium sulfate. Fetal Diagn Ther. 2018; 44(1): 59-64.

[10] Benchmarking against the MOMS Trial: Zurich Results of Open Fetal Surgery for Spina Bifida, Fetal Diagn Ther 2020;47:91-97, DOI: 10.1159/ 000500049

## Section 3
